This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

Verdict

Headline leans bearish. We score VKTX +1.00.

Score contradicts the headline.

Headline says

Leans bearish

From its wording — no explicit rating

≠

Expected · VKTX

+1.00strongly bullish